222 related articles for article (PubMed ID: 30359271)
1. FBXO17 promotes cell proliferation through activation of Akt in lung adenocarcinoma cells.
Suber TL; Nikolli I; O'Brien ME; Londino J; Zhao J; Chen K; Mallampalli RK; Zhao Y
Respir Res; 2018 Oct; 19(1):206. PubMed ID: 30359271
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of FBXO17 Promotes the Proliferation, Migration and Invasion of Glioma Cells Through the Akt/GSK-3β/Snail Pathway.
Wang N; Song Q; Yu H; Bao G
Cell Transplant; 2021; 30():9636897211007395. PubMed ID: 33853342
[TBL] [Abstract][Full Text] [Related]
3. SCF
Suber T; Wei J; Jacko AM; Nikolli I; Zhao Y; Zhao J; Mallampalli RK
J Biol Chem; 2017 May; 292(18):7452-7461. PubMed ID: 28298444
[TBL] [Abstract][Full Text] [Related]
4. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma.
Song YH; Zhang CQ; Chen FF; Lin XY
Chin Med J (Engl); 2018 Jan; 131(1):16-24. PubMed ID: 29271375
[TBL] [Abstract][Full Text] [Related]
6. Paip1 predicts poor prognosis and promotes tumor progression through AKT/GSK-3β pathway in lung adenocarcinoma.
Wang Y; Piao J; Wang Q; Cui X; Meng Z; Jin T; Lin Z
Hum Pathol; 2019 Apr; 86():233-242. PubMed ID: 30496797
[TBL] [Abstract][Full Text] [Related]
7. [High expression of VEGFR3 is positively associated with poor prognosis in lung adenocarcinoma].
Li J; Zhang W; Xia H; Liu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1023-1029. PubMed ID: 31878999
[TBL] [Abstract][Full Text] [Related]
8. KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma.
Ji Z; Pan X; Shang Y; Ni DT; Wu FL
Tissue Cell; 2019 Dec; 61():44-50. PubMed ID: 31759406
[TBL] [Abstract][Full Text] [Related]
9. RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway.
Jin X; Di X; Wang R; Ma H; Tian C; Zhao M; Cong S; Liu J; Li R; Wang K
J Cell Mol Med; 2019 Jun; 23(6):3897-3904. PubMed ID: 30955253
[TBL] [Abstract][Full Text] [Related]
10. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis.
Ye L; Pu C; Tang J; Wang Y; Wang C; Qiu Z; Xiang T; Zhang Y; Peng W
Respir Res; 2019 May; 20(1):106. PubMed ID: 31142317
[TBL] [Abstract][Full Text] [Related]
12. DRAM1 regulates autophagy and cell proliferation via inhibition of the phosphoinositide 3-kinase-Akt-mTOR-ribosomal protein S6 pathway.
Lu T; Zhu Z; Wu J; She H; Han R; Xu H; Qin ZH
Cell Commun Signal; 2019 Mar; 17(1):28. PubMed ID: 30902093
[TBL] [Abstract][Full Text] [Related]
13. Pellino-1 promotes lung carcinogenesis via the stabilization of Slug and Snail through K63-mediated polyubiquitination.
Jeon YK; Kim CK; Hwang KR; Park HY; Koh J; Chung DH; Lee CW; Ha GH
Cell Death Differ; 2017 Mar; 24(3):469-480. PubMed ID: 28009353
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of PAR-1 Receptor Signaling by Enoxaparin Reduces Cell Proliferation and Migration in A549 Cells.
Alturkistani A; Ghonem N; Power-Charnitsky VA; Pino-Figueroa A; Migliore MM
Anticancer Res; 2019 Oct; 39(10):5297-5310. PubMed ID: 31570424
[TBL] [Abstract][Full Text] [Related]
15. [The effects of Tumstatin185-191 on lung adenocarcinoma cell lines and the association with protein kinase B and extracellular regulated protein kinase activation].
Wang W; Chen P; Li JL; Pei YF; Shuang QC; Liu CH; Cai S; Liu SK; Zhu LY; Zhou R
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):123-7. PubMed ID: 20367953
[TBL] [Abstract][Full Text] [Related]
16. Serous IFNA3 predicts unfavorable prognosis in lung cancer via abnormal activation of AKT signaling.
Ge Q; Cong P; Ji Y
IUBMB Life; 2019 Nov; 71(11):1806-1814. PubMed ID: 31419016
[TBL] [Abstract][Full Text] [Related]
17. Claudin-18 inhibits cell proliferation and motility mediated by inhibition of phosphorylation of PDK1 and Akt in human lung adenocarcinoma A549 cells.
Shimobaba S; Taga S; Akizuki R; Hichino A; Endo S; Matsunaga T; Watanabe R; Yamaguchi M; Yamazaki Y; Sugatani J; Ikari A
Biochim Biophys Acta; 2016 Jun; 1863(6 Pt A):1170-8. PubMed ID: 26919807
[TBL] [Abstract][Full Text] [Related]
18. Decreasing Arl4c expression by inhibition of AKT signal in human lung adenocarcinoma cells.
Sun Y; Zhang Z; Xiang F; Zhang M; Chen Q; Tang L; Zhu L; Liu J; Meng Z; Hu J; Luo X; Ni Z; Wang X
Life Sci; 2020 Apr; 246():117428. PubMed ID: 32057901
[TBL] [Abstract][Full Text] [Related]
19. USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51-AKT1 signaling.
Zhao X; Wu X; Wang H; Yu H; Wang J
Mol Carcinog; 2020 Aug; 59(8):1000-1011. PubMed ID: 32511815
[TBL] [Abstract][Full Text] [Related]
20. Apigenin inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line.
Zhou Z; Tang M; Liu Y; Zhang Z; Lu R; Lu J
Anticancer Drugs; 2017 Apr; 28(4):446-456. PubMed ID: 28125432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
